Post by Apellis Pharmaceuticals

We are pleased to announce that Apellis has agreed to be acquired by Biogen. This transaction reflects the transformational impact of our medicines for patients, the strength of our science, and the extraordinary talent of our team. With its resources, scale, and global reach, Biogen is the right partner to accelerate our growth and reach even more patients. Learn more: https://bit.ly/4chgv60